MedTrace Logo

Anidulafungin Pharmacokinetics in Intensive Care Unit Patients

NCT01438216 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2011-09-22

No results posted yet for this study

Summary

The purpose of this study is to determine the pharmacokinetics of anidulafungin in intensive care patients.

Conditions

  • Invasive Candidiasis
  • Candidemia

Sponsors & Collaborators

  • Radboud University Medical Center

    collaborator OTHER

  • Amsterdam UMC, location VUmc

    lead OTHER

Principal Investigators

  • Vera M Middel-Baars, PharmD · Amsterdam UMC, location VUmc

  • Eleonora L Swart, PhD · Amsterdam UMC, location VUmc

  • Roger Brüggemann, PharmD · Radboud University Nijmegen Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-02-29
Completion
2012-03-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01438216 on ClinicalTrials.gov